GTCB

GTCB: To Present At Rodman & Renshaw Investment Conference @ 10:20 ET [delayed] - 11/11 - 08:53 AM ET

GTC Biotherapeutics Receives NASDAQ Notice - 11/11 - 07:00 AM ET

Research and Markets: GTC Biotherapeutics Inc Is Working With LFB Biotechnologies to Develop Recombinant Forms of Human Factor VIIa and A CD20 Monoclonal Antibody - 11/06 - 09:44 AM ET

GTC Biotherapeutics to Webcast Corporate Presentation at the Rodman & Renshaw 10th Annual Healthcare Conference - 11/05 - 09:10 AM ET

GTC Biotherapeutics Inc signs debt financing agreement with LFB Biotechnologies - 11/04 - 04:13 AM ET

GTCB: Conference call regarding Reports Third Quarter 2008 Financial Results @ 10:00 ET Today [delayed] - 11/03 - 09:33 AM ET

BRIEF-GTC Biotherapeutics Q3 results - 11/03 - 08:07 AM ET

GTC Biotherapeutics Reports Third Quarter 2008 Financial Results - 11/03 - 08:00 AM ET

GTC Signs Agreement for $15 Million Convertible Debt Financing From LFB - 11/03 - 07:00 AM ET

GTC Biotherapeutics to Announce Third Quarter 2008 Earnings on Monday, November 3, 2008 - 10/29 - 03:52 PM ET

Ovation Pharmaceuticals's ATryn BLA accepted for review by FDA - 10/07 - 07:58 AM ET

ATryn(R) (antithrombin alfa) BLA Filing Accepted by FDA - 10/06 - 09:43 AM ET

GTCB: FDA Accepts BLA Filing for ATryn(R) - 10/06 - 08:47 AM ET

GTC BIOTHERAPEUTICS INC SAYS ATRYN(R) BLA WILL ALSO RECEIVE PRIORITY REVIEW - 10/06 - 08:05 AM ET

FDA Accepts ATryn(R) BLA Filing - 10/06 - 08:00 AM ET

GTC Biotherapeutics's thrombosis drug granted FDA priority review - 09/05 - 09:30 AM ET

GTC BIOTHERAPEUTICS UP 5.9% TO 54C; RECEIVES PRIORITY REVIEW FROM FDA - 09/04 - 09:51 AM ET

GTC Biotherapeutics gets FDA priority review for ATryn - 09/04 - 08:17 AM ET

GTC BIOTHERAPEUTICS GETS PRIORITY REVIEW FOR ATRYN FROM FDA - 09/04 - 08:13 AM ET

GTC Biotherapeutics and Ovation close agreement for antithrombin drug - 08/18 - 12:49 PM ET

Page 1 of 5     1  2   3   4   5      Previous  |  Next

<< Back to Stock Index